ECigIntelligence

Regulatory and market intelligence for the e-cigarette sector

Regulatory briefing

How will the US FDA resolve the 1.5m pending PMTAs?

Written by || 11th August 2021 || Regulatory briefing | FDA | Regulation and Legislation | North America United States

After the recent announcement that FDA rejected 4.5m of the total 6m PMTAs filed, experts believe that this decision is a clear path for enforcement ...

Restricted content. Do you want to read more?

Read our latest free content

Turning Point Brands seeks emergency court ruling against FDA denial order
A hammer to crack a nut: what the PMTA process reveals about US FDA approach
US FDA questioned about pending PMTAs and enforcement for non-compliance
Reporting disorder: don’t let the facts get in the way of a good bad-news story
BAT urges Middle Eastern governments to adopt tobacco harm reduction
‘Significant progress’ – but the US FDA’s biggest decisions are still to come

Featured news

Australian consumers will be able to obtain medically licensed nicotine-containing e-cigarettes from community and online pharmacies

There is still some mystery around how the new system will be implemented. How will Australia’s new sales regime work?

International | Regulation & legislation | Blog 

Sign up to our newsletter

By signing up you agree to our Terms and Conditions